Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALL.

El Chaer, F; Holtzman, N; Binder, E; Porter, N C; Singh, Z N; Koka, M; Rapoport, A P; Emadi, A

El Chaer, F; Holtzman, N; Binder, E; Porter, N C; Singh, Z N; Koka, M; Rapoport, A P; Emadi, A.

Affiliation

El Chaer F; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Holtzman N; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Binder E; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Porter NC; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Singh ZN; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Koka M; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Rapoport AP; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
Emadi A; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.

Bone Marrow Transplant ; 52(11): 1583-1584, 2017 11.

Article in En | MEDLINE | ID: mdl-28892087

Subject(s)

Azacitidine/analogs & derivatives; Lymphocyte Transfusion/methods; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/therapy; Salvage Therapy/methods; Aged; Azacitidine/therapeutic use; Decitabine; Humans; Male; Remission Induction/methods; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Salvage Therapy / Lymphocyte Transfusion / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Limits: Aged / Humans / Male Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google